HLA Typing and HLA Antibody Testing Market: HLA Typing, HLA Antibody Testing, Single Antigen, Post-Transplant Test,), and Geography  

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

HLA Typing and HLA Antibody Testing Market Size, Share, Growth, Trends, and Global Industry Analysis: HLA Typing ( Lab Type, Typing Technology, Type), HLA Antibody Testing (Screening, PRA (Panel Reactive Antibody), Single Antigen, Post-Transplant Test,), and Region  

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

1. Executive Summary
2. Global HLA Typing and HLA Antibody Testing Market Introduction
2.1. Global HLA Typing and HLA Antibody Testing Market – Taxonomy
2.2. Global HLA Typing and HLA Antibody Testing Market –Definitions
2.2.1. HLA Typing
2.2.2. HLA Antibody Testing
2.2.3. Region
3. Global HLA Typing and HLA Antibody Testing Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Epitope Analysis
3.6. Reimbursement Scenario in USA and Europe
3.7. Global HLA Typing and HLA Antibody Testing Market Dynamic Factors - Impact Analysis
3.8. Number of Transplantations in USA and Europe
3.9. New Product Launches
3.10. Licensing, Mergers and Acquisitions
4. Global HLA Typing and HLA Antibody Testing Market Analysis, 2017 – 2021 and Forecast, 2022 - 2028
4.1. Market Analysis, 2017-2018 and Forecast, 2022 - 2028 (Revenue, US$ Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global HLA Typing and HLA Antibody Testing Market, By HLA Typing, 2017-2018 and Forecast, 2022 - 2028 (Revenue, US$ Mn)
5.1. Lab Type
5.1.1. In Lab
5.1.1.1. Market Analysis, 2017-2018 and Forecast, 2022 - 2028 (Revenue, US$ Mn)
5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.1.3. Market Opportunity Analysis
5.1.2. Out Sourced
5.1.2.1. Market Analysis, 2017-2018 and Forecast, 2022 - 2028 (Revenue, US$ Mn)
5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.2.3. Market Opportunity Analysis
5.2. Typing Technology
5.2.1. qPCR
5.2.1.1. Market Analysis, 2017-2018 and Forecast, 2022 - 2028 (Revenue, US$ Mn)
5.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.1.3. Market Opportunity Analysis
5.2.2. SSO
5.2.2.1. Market Analysis, 2017-2018 and Forecast, 2022 - 2028 (Revenue, US$ Mn)
5.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.2.3. Market Opportunity Analysis
5.2.3. NGS
5.2.3.1. Market Analysis, 2017-2018 and Forecast, 2022 - 2028 (Revenue, US$ Mn)
5.2.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3.3. Market Opportunity Analysis
5.3. Type
5.3.1. Patient
5.3.1.1. Market Analysis, 2017-2018 and Forecast, 2022 - 2028 (Revenue, US$ Mn)
5.3.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.1.3. Market Opportunity Analysis
5.3.2. Registry
5.3.2.1. Market Analysis, 2017-2018 and Forecast, 2022 - 2028 (Revenue, US$ Mn)
5.3.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.2.3. Market Opportunity Analysis
6. Global HLA Typing and HLA Antibody Testing Market, By HLA Antibody Testing, 2017-2018 and Forecast, 2022 - 2028 (Revenue, US$ Mn)
6.1. Screening
6.1.1. Market Analysis, 2017-2018 and Forecast, 2022 - 2028 (Revenue, US$ Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. PRA (Panel Reactive Antibody)
6.2.1. Market Analysis, 2017-2018 and Forecast, 2022 - 2028 (Revenue, US$ Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Single Antigen
6.3.1. Market Analysis, 2017-2018 and Forecast, 2022 - 2028 (Revenue, US$ Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Post Transplant Test
6.4.1. Market Analysis, 2017-2018 and Forecast, 2022 - 2028 (Revenue, US$ Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
7. Global HLA Typing and HLA Antibody Testing Market Forecast, By Region, 2017-2018 and Forecast, 2022 - 2028 (Revenue, US$ Mn)
7.1. North America
7.1.1. Market Analysis, 2017-2018 and Forecast, 2022 - 2028 (Revenue, US$ Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Europe
7.2.1. Market Analysis, 2017-2018 and Forecast, 2022 - 2028 (Revenue, US$ Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
7.3.1. Market Analysis, 2017-2018 and Forecast, 2022 - 2028 (Revenue, US$ Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. RoW
7.4.1. Market Analysis, 2017-2018 and Forecast, 2022 - 2028 (Revenue, US$ Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Global HLA Typing and HLA Antibody Testing Market - Opportunity Analysis Index, By HLA Typing, Antibody Testing, and Region, 2022 - 2028
8. North America HLA Typing and HLA Antibody Testing Market Analysis, 2017-2018 and Forecast, 2022 - 2028 (Revenue, US$ Mn)
8.1. HLA Typing Analysis 2017-2018 and Forecast 2022 - 2028 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%)
8.1.1. Lab Type
8.1.1.1. In Lab
8.1.1.2. Outsource
8.1.2. Typing Technology
8.1.2.1. qPCR
8.1.2.2. SSO
8.1.2.3. NGS
8.1.3. Type
8.1.3.1. Patient
8.1.3.2. Registry
8.2. HLA Antibody Testing Analysis 2017-2018 and Forecast 2022 - 2028 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%)
8.2.1. Screening
8.2.2. PRA (Panel Reactive Antibodies)
8.2.3. Single Antigen
8.2.4. Post Transplant
8.3. Country Analysis 2017 and Forecast 2022 - 2028 by Revenue (US$ Mn) Y-o-Y Growth (%) and Market Share (%)
8.3.1. U.S.
8.3.2. Canada
8.4. North America HLA Typing and HLA Antibody Testing Market - Opportunity Analysis Index, By HLA Typing, Antibody Testing, and Country, 2019-2025
8.5. North America HLA Typing and HLA Antibody Testing Market Dynamics – Trends
9. Europe HLA Typing and HLA Antibody Testing Market Analysis, 2017-2018 and Forecast, 2022 - 2028 (Revenue, US$ Mn)
9.1. HLA Typing Analysis 2017-2018 and Forecast 2022 - 2028 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Lab Type
9.1.1.1. In Lab
9.1.1.2. Outsource
9.1.2. Typing Technology
9.1.2.1. qPCR
9.1.2.2. SSO
9.1.2.3. NGS
9.1.3. Type
9.1.3.1. Patient
9.1.3.2. Registry
9.2. HLA Antibody Testing Analysis 2017-2018 and Forecast 2022 - 2028 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%)
9.2.1. Screening
9.2.2. PRA (Panel Reactive Antibodies)
9.2.3. Single Antigen
9.2.4. Post Transplant
9.3. Country Analysis 2017-2018 and Forecast 2022 - 2028 by Revenue (US$ Mn) Y-o-Y Growth (%) and Market Share (%)
9.3.1. Germany
9.3.2. UK
9.3.3. Spain
9.3.4. Italy
9.3.5. France
9.3.6. Rest of Europe
9.4. Europe HLA Typing and HLA Antibody Testing Market - Opportunity Analysis Index, By HLA Typing, Antibody Testing, and Country, 2019-2025
9.5. Europe HLA Typing and HLA Antibody Testing Market Dynamics – Trends
10. Asia-Pacific HLA Typing and HLA Antibody Testing Market Analysis, 2017-2018 and Forecast, 2022 - 2028 (Revenue, US$ Mn)
10.1. HLA Typing Analysis 2017-2018 and Forecast 2022 - 2028 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Lab Type
10.1.1.1. In Lab
10.1.1.2. Outsource
10.1.2. Typing Technology
10.1.2.1. qPCR
10.1.2.2. SSO
10.1.2.3. NGS
10.1.3. Type
10.1.3.1. Patient
10.1.3.2. Registry
10.2. HLA Antibody Testing Analysis 2017-2018 and Forecast 2022 - 2028 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Screening
10.2.2. PRA (Panel Reactive Antibodies)
10.2.3. Single Antigen
10.2.4. Post Transplant
10.3. Country Analysis 2017-2018 and Forecast 2022 - 2028 by Revenue (US$ Mn) Y-o-Y Growth (%) and Market Share (%)
10.3.1. Japan
10.3.2. China
10.3.3. India
10.3.4. Australia and New Zealand
10.3.5. Rest of Asia-Pacific
10.4. Asia-Pacific HLA Typing and HLA Antibody Testing Market - Opportunity Analysis Index, By HLA Typing, Antibody Testing, and Country, 2019-2025
10.5. Asia-Pacific HLA Typing and HLA Antibody Testing Market Dynamics – Trends
11. RoW HLA Typing and HLA Antibody Testing Market Analysis, 2017-2018 and Forecast, 2022 - 2028 (Revenue, US$ Mn)
11.1. HLA Typing Analysis 2017-2018 and Forecast 2022 - 2028 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Lab Type
11.1.1.1. In Lab
11.1.1.2. Outsource
11.1.2. Typing Technology
11.1.2.1. qPCR
11.1.2.2. SSO
11.1.2.3. NGS
11.1.3. Type
11.1.3.1. Patient
11.1.3.2. Registry
11.2. HLA Antibody Testing Analysis 2017-2018 and Forecast 2022 - 2028 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Screening
11.2.2. PRA (Panel Reactive Antibodies)
11.2.3. Single Antigen
11.2.4. Post Transplant
11.3. Country Analysis 2017-2018 and Forecast 2022 - 2028 by Revenue (US$ Mn) Y-o-Y Growth (%) and Market Share (%)
11.3.1. Saudi Arabia
11.3.2. Turkey
11.3.3. Brazil
11.3.4. Rest of RoW
11.4. RoW HLA Typing and HLA Antibody Testing Market - Opportunity Analysis Index, By HLA Typing, Antibody Testing, and Country, 2019-2025
11.5. RoW HLA Typing and HLA Antibody Testing Market Dynamics – Trends
12. Competition Landscape 
12.1. Strategic Dashboard of Top Market Players
12.2. Company Profiles (Introduction, Financial Analysis, Drug Class & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
12.2.1. One Lamba
12.2.2. Immucor Inc.,
12.2.3. Bio-Rad Laboratories, Inc
12.2.4. F. Hoffmann-La Roche Ltd
12.2.5. QIAGEN N.V
12.2.6. One Lambda (Thermo Fisher Scientific Inc.)
12.2.7. Becton, Dickinson and Company
12.2.8. BAG Health Care GmbH
12.2.9. CareDx Inc
13. Research Methodology
14. Key Assumptions and Acronyms

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

Key Market Players

  • One Lamba
  • Immucor Inc.,
  • Bio-Rad Laboratories, Inc
  • QIAGEN N.V
  • One Lambda (Thermo Fisher Scientific Inc.)
  • Becton, Dickinson and Company
  • BAG Health Care GmbH
  • CareDx Inc
  • Hoffmann-La Roche Ltd

Related Industry Reports

Chronic Refractory Gout Pharmaceuticals Market

Familial Mediterranean Fever Pharmaceuticals Market

Australia Point of Care Diagnostics Market

Aseptic Sampling Market